Table 1 Characteristics, treatments, and outcomes of patients admitted with history of heart failure.
| With prior heart failure (n = 139) | No prior heart failure (n = 907) | p Value | |
|---|---|---|---|
| Age (SD) | 72.8 (9.7 | 64.7 (11.8 | <0.001 |
| >70 (%) | 65.5 | 36.3 | <0.001 |
| Female (%) | 50.4 | 37.6 | 0.004 |
| Diabetes (%) | 25.9 | 14.8 | 0.001 |
| Hypertension (%) | 43.9 | 36.1 | 0.08 |
| Prior MI (%) | 68.4 | 45.1 | <0.001 |
| Prior PTCA | 14.4 | 13.2 | 0.71 |
| Prior CABG | 20.9 | 12.5 | 0.007 |
| Prior angina | 91.4 | 71.9 | <0.001 |
| Admission ECG | |||
| ST depression/BBB (%) | 46.0 | 26.5 | <0.001 |
| Other (T, etc) (%) | 48.2 | 56.1 | |
| Normal (%) | 5.8 | 17.4 | |
| In‐hospital treatment | |||
| Aspirin (%) | 79.1 | 88.5 | 0.002 |
| LMWH (%) | 38.1 | 44.9 | 0.14 |
| IV UFH (%) | 33.6 | 33.6 | 1.0 |
| Either LMWH or IV UFH (%) | 70.5 | 77.8 | 0.08 |
| Treatment at six months | |||
| Aspirin (%) | 73.6 | 83.4 | 0.008 |
| β blockers (%) | 17.4 | 46.1 | <0.001 |
| Ca channel antagonists (%) | 45.5 | 43.3 | 0.65 |
| Nitrate (%) | 75.2 | 55.4 | <0.001 |
| K channel opener (%) | 31.4 | 18.8 | 0.001 |
| Statins (%) | 35.5 | 48.3 | 0.008 |
| Oral anticoagulants (%) | 20.7 | 8.9 | <0.001 |
| ACE inhibitors (%) | 58.7 | 28.2 | <0.001 |
| α2 antagonists (%) | 10.7 | 2.8 | <0.001 |
| In‐hospital investigation | |||
| Stress test (%) | 4.3 | 14.2 | 0.001 |
| Investigation at six months | |||
| Angiography (%) | 17.3 | 29.2 | 0.003 |
| PTCA (%) | 5.0 | 8.4 | 0.17 |
| CABG (%) | 5.0 | 7.5 | 0.3 |
| All events to follow up | |||
| Death (%) | 18.7 | 5.5 | <0.001 |
| Death/MI (%) | 23.8 | 10.8 | <0.001 |
| Death/MI/RFA/UA (%) | 42.8 | 27.8 | <0.001 |
| Heart failure | 42.5 | 6.5 | <0.001 |
| Major bleed | 4.3 | 0.8 | <0.001 |